Heart diseases are an important cause of morbidity and mortality in industrialized countries. Dilated cardiomyopathy (DCM), one of the most common heart diseases, may be the consequence of infectionassociated myocardits. Coxsackievirus B3 (CVB3) can be frequently detected in the inflamed heart muscle. CVB3-induced acute myocarditis is most likely the consequence of direct virus-induced myocyte damage, whereas chronic CVB3 infection-associated heart disease is dominated by its immunopathological sequelae. Bona fide autoimmunity, for example, directed against cardiac myosin, may favor chronic destructive immune damage in the heart muscle and thereby promote the development of DCM. The immunopathogenesis of myocarditis and subsequent DCM induced either by pathogens or autoantigens can be investigated in well-established animal models. In this article, we review recent studies on the role of viruses, with particular emphasis on CVB3, and different immunological effector mechanisms in initiation and progression of myocarditis.
INTRODUCTION
Infections with viruses, protozoan intracellular parasites or bacteria may be associated with myocarditis (Brown and O'Connell, 1995; Bowles et al., 2003) . Even vaccination efforts, such as recent vaccinia virus programs are a potential cause of cardiac adverse events (Murphy et al., 2003) . The most commonly known viral infectant of the heart are the Coxsackie B group viruses (CVB) in the Picornaviridae family. CVB3 RNA, for example, can be detected in the heart muscle of 40 -50% of patients with dilated cardiomyopathy (DCM) (Fenoglio et al., 1983; James, 1983; Dec et al., 1985; Keating and Sanguinetti, 1996) and serological studies have shown a strong correlation between the presence of CVB3-specific antibodies and myocarditis (El-Hagrassy et al., 1980) . Furthermore, CVB3 infection has been proposed to be the major cause of pediatric myocarditis (Kaplan et al., 1983) .
Humans are the natural host for CVB3. The ability of this virus to infect mice and the susceptibility of specific mouse strains for CVB3-induced myocarditis provides a model system for the investigation of CVB3-induced immunopathological heart disease. Depending on the genetic background, the experimental disease in mice can be monophasic (acute myocarditis) or biphasic (acute myocarditis and subsequent low-grade inflammation).
In the second phase of the biphasic myocarditis, infectious virus is usually no longer detectable and ongoing inflammation leads to heart muscle fibrosis and ventricular dilation. Mouse strains showing a biphasic disease progression are thus well-suited to study the shift from a viral infection with local tissue destruction to the induction of chronic immune responses to autoantigens (Kawai, 1999; Feldman et al., 2000; Cunningham, 2001) .
ACUTE CVB3-INDUCED MYOCARDITIS
In situ hybridization and gene amplification studies support the notion that viral infection and persistence of viral RNA may lead to direct cytopathic damage of cardiomyocytes Klingel and Kandolf, 1993; Saraste et al., 2003) . The high cytopathogenic potential of CVB3 can be demonstrated in vitro by rapid lysis of cardiomyocytes (Herzum et al., 1994) , and in vivo in SCID mice lacking B-and T-cells, where the uncontrolled replication of CVB3 leads to severely enhanced myocardial damage (Chow et al., 1992) . Cell death occurring in the early phase of the infection may be a trigger for the subsequent inflammation. The early infiltrate in hearts of CVB3 infected mice consists of macrophages and T cells and a large proportion of the T cells express the gd T cell receptor (TCR) (Godeny and Gauntt, 1987a; Henke et al., 1995) . In CVB infected humans, macrophages and T cells are found among the infiltrating cells and a predominance of the Vb7 TCR was described (Luppi et al., 2003) .
An early and efficient immune response is essential for the protection against cytopathic viruses (Zinkernagel, 1996) . However, the immune response against CVB3 may be a double-edged sword. For example, depletion of abT cells from CVB3-infected mice leads to a marked reduction in myocardial damage, despite comparable virus titers to control animals (Kishimoto and Abelmann, 1989) . Likewise, gdT cells may contribute to immunopathological damage of cardiomyocytes (Huber, 2000; Huber et al., 2001) . A recent study by Huber and colleagues shows that CD1d-restricted gdT cells significantly promote the initial myocardial damage, but are not essential for viral clearance (Huber et al., 2003) . These results emphasize that it is most likely the quality of the initial anti-CVB3 response that sets the stage for the chronic immunopathological damage of the heart muscle.
Innate Immune Responses in Early Virus-induced Myocarditis
Natural killer (NK) cells are able to inhibit the replication of CVB3 as shown by the fact that NK cell depletion leads to increased viral titers and more severe myocarditis (Godeny and Gauntt, 1987b; Godeny and Gauntt, 1986 ). The complement system may play a role in CVB3-induced myocarditis because C3, for example, is involved in antigen retention in germinal centers and viral clearance from spleen (Anderson et al., 1997) . Furthermore, it has been clearly shown for myosin-induced experimental autoimmune myocarditis that the presence of complement receptor type I and II expressed on a subset of T cells is important for myocarditis induction . Toll-like receptors (TLRs) are important for recognition of conserved microbial structures and subsequent activation of innate immune responses. In CVB3 infection, both myocarditis and viral replication are significantly reduced in the absence of TLR4 (Fairweather et al., 2003) . The availability of knockout mice for the several TLR types will help to further clarify the role of the innate immune system for CVB3-induced myocarditis.
Adaptive Immune Responses in Virus-induced Myocarditis
The prominent role of T cells for the induction and/or severity of myocarditis is known since the pioneering work of Woodruff and Woodruff (1974) who showed that T cell-depleted mice suffer less from severe CVBmediated myocarditis than control mice. Similarly, athymic nude mice show reduced disease after CVB3 infection (Hashimoto and Komatsu, 1978) . Gene-deficient mice have been used to further delineate the immunopathological mechanisms in CVB3-induced myocarditis (Table I) . CD8-deficient mice showed reduced survival after CVB3 infection, but showed no difference in the degree of myocarditis indicating that the contribution of CD8 T cells in immune-mediated heart inflammation is limited (Opavsky et al., 1999) . Studies in mice lacking the dominant effector molecule of cytotoxic T cells, perforin, provided conflicting results concerning the contribution of this molecule in CVB3 infection. Gebhard and colleagues showed that perforin-knockout mice survive CVB3 infection and that infection-associated myocarditis is less severe (Gebhard et al., 1998) . However, other studies could not detect significant differences between wild-type and perforin-knockout mice after CVB3 infection (Klingel et al., 2003) . The reason for these differences remains so far elusive, but the results from both studies clearly indicate that perforin is not essential for CVB3 elimination. An important role for T helper cells in the development of myocarditis is indicated by the fact that both CD4/CD8-and abTCR-deficient mice show an increased survival rate and reduced myocardial damage after CVB3 infection (Opavsky et al., 1999) . Furthermore, CVB3 elicits only mild myocarditis in mice lacking only the CD4 molecule (Opavsky et al., 1999) . Importantly, in this series of experiments, virus titers in the hearts of CD8-, CD4-, C4/CD8-and TCR-ab-deficient mice were comparable in the first week post infection (Opavsky et al., 1999) demonstrating that the extent of myocardial injury is mainly determined by immunopathological mechanisms. Recent work supports the notions that gd T cells play a prominent role in CVB3-induced myocarditis (Huber, 2000; Huber et al., 2002) . The finding that at least a fraction of these gd T cells are CD1d-restricted (Huber et al., 2003) will stimulate the search for unconventional (lipid?) antigens that trigger gd TCRs in myocarditis.
Infection of humans and mice by CVB3 as well as MCMV infection of mice induces the production of autoantibodies to cardiac myosin and other heart antigens (Neu et al., 1990; O'Donoghue et al., 1990; Lauer et al., 1994) . These antibodies appear earliest on day 7 post infection in CVB3 infected mice and can be eluted from the heart muscle (Neumann et al., 1994; Latif et al., 1999) . The question that arises is whether these autoantibodies play a critical role for the onset and progression of autoimmune myocarditis. Studies on CVB3 infection in B cell-deficient mice indicated that antibodies are not important for the development of myocarditis and disease progression, but play a prominent role in the control of the infection (Mena et al., 1999) . However, B cells secreting heart-specific autoantibodies may impact on immunemediated myocardial inflammation. For example, antimyosin antibodies can mediate myocarditis in susceptible mouse strains and disease susceptibility depends on the presence of myosin or a myosin-like molecule in cardiac extracellular matrix (Liao et al., 1995) . Furthermore, a recent report revealed that DCM in the negative immune regulatory receptor PD-1-knockout mice is mediated by autoantibodies reactive to cardiomyocytes (Nishimura et al., 2001) . Autoantibodies recognizing extracellularly deposited cardiac troponin I (cTn I) induced dilatation and dysfunction of the heart by induction of a permanent influx of Ca 2þ in cardiomyocytes. Interestingly, the presence of cTn I-specific antibodies in the heart did not induce inflammation, despite the formation of immune complexes (Okazaki et al., 2003) . It is noteworthy that in this particular experimental setting, myocarditis is not a prerequisite for the development of immune-mediated DCM.
Immune Mechanisms in Autoimmune Myocarditis
The best-studied cardiac autoantigen is the alpha chain of cardiac myosin. Immunization of susceptible mice with myosin protein or defined, MHC class II restricted myosin peptides induces myocarditis (Neu et al., 1987 ) (see Fig. 1 ). This experimental approach uncouples the chronic phase from the virus infection, and is therefore a valuable tool to study the mechanisms and effector molecules involved in autoimmune myocarditis and to evaluate therapeutic strategies. As shown in adoptive transfer experiments, the inflammatory response in autoimmune myocarditis is mediated by Th cells. Transfer of CD4 T cells from peptide-immunized mice induces myocarditis in non-immunized mice (Smith and Allen, 1991) . In addition, the injection of anti-MHC II antibodies prevents disease (Pummerer et al., 1991) . Induction of autoimmune myocarditis in mice strongly depends on the genetic background and the MHC II locus (Neu et al., 1987) . Likewise, human chronic heart disease has also been correlated to certain HLA alleles and experiments in transgenic mice expressing human CD4 and HLA-DQ6 show that genetically resistant C57BL/6 mice may become susceptible to autoimmune myocarditis (Bachmaier et al., 1999) . Autoimmune damage in the heart by Th cells is most likely mediated via local interaction with professional antigen-presenting cells (APCs) because myocytes do not express MHC II molecules. It has been demonstrated that expression of myosin-MHC II complexes are presented by resident heart APC and that the presentation of this antigen precedes the infiltration of T cells (Smith and Allen, 1992) . Furthermore, MHC II upregulation in the heart is a prerequisite for disease induction as shown in tumor necrosis factor (TNF)-Rp55-deficient mice, where MHC II upregulation is abrogated (Bachmaier et al., 1997) . Other proinflammotory cytokines such as IL-12 and IFN-g have been shown to be involved in the pathogenesis of autoimmune myocarditis. IL-12, like TNF-a, is important for the onset of disease and IFN-g seems to play a protective role via the induction of nitric oxide Eriksson et al., 2001a,b) . As mentioned above, complement receptors I and II expression on a subset of T cells is important for the onset of autoimmune myocarditis ). Furthermore, it was shown that dendritic cellinduced autoimmune myocarditis requires cooperation between adaptive and innate immune responses (Eriksson et al., 2003) . Further studies using transgenic mice and genetically modified viruses will help to shed light on the complex mechanisms operative in autoimmune myocarditis. 
VIRUS-INDUCED MYOCARDITIS

CONCLUSION
The etiological link between infection, myocarditis and subsequent DCM is well-established in humans. Furthermore, the shift from pathogen-induced myocarditis to an autoimmune-mediated chronic degenerative heart disease is well-documented in animal models. It has been proposed that breaking of self-tolerance to autoantigens is mediated by molecular mimicry, bystander activation or epitope spreading (Vanderlugt and Miller, 2002) . Although the contribution of these immunopathological mechanisms has been studied in other virus infections such as Theiler's virus (Vanderlugt and Miller, 2002) or lymphocytic choriomeningitis virus (Zinkernagel, 2002) , a detailed analysis for CVB3 infection is still lacking. The knowledge how CVB3 and maybe other infectious agents cause myocarditis and subsequent DCM will make these diseases amenable to new treatment options such as immunosuppression (Frustaci et al., 2002) or immunomodulation (Fig. 1) .
